Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Lung Cancer. 2017 Mar 1;108:62–65. doi: 10.1016/j.lungcan.2017.02.024

Table 1.

Incidence of thoracic metastases in patients with BRAF mutated lung cancer with and without axillary nodal metastases. Abbreviations: LN = lymph node, axLN = axillary lymph node, +ve = positive, −ve = negative.

BRAF Patients (N = 46) axLN metastasis +ve axLN metastasis −ve
Total number 7 39
Supraclavicular LN metastases 2 (29%) 7 (18%)
Mediastinal LN metastases 7 (100%) 24 (62%)
Pleural metastases 3 (43%) 13 (33%)
Chest wall invasion 0 (0%) 1 (3%)
Lung metastases 3 (43%) 22 (56%)
Lymphangitis carcinomatosis 1 (14%) 4 (10%)